95
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Progress in the Clinical Assessment and Treatment of Myocardial Depression in Critically Ill Patient with Sepsis

, , , , , & show all
Pages 5483-5490 | Received 24 Jun 2022, Accepted 17 Aug 2022, Published online: 20 Sep 2022

References

  • Cao Y, Chai Y, Deng Y, et al. Chinese guidelines for emergency management of sepsis and septic shock. Infect Inflamm Repair. 2019;20(1):3–22.
  • Perner A, Cecconi M, Cronhjort M. Expert statement for the management of hypovolemia in sepsis. Intensive Care Med. 2018;44:791–798. doi:10.1007/s00134-018-5177-x
  • Shang N, Liu H, Wang N. 脓毒性心肌病临床诊断评分体系的 构建及效能评估 [Establishment and evaluation of clinical diagnostic scoring system for septic cardiomyopathy]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021;33:1409–1413. Chinese. doi:10.3760/cma.j.cn121430-20210618-0913
  • Huang Y, Huo B, Luo W. Effect of myocardial inhibition on cardiac function and prognosis in patients with sepsis. Chin J Med Sci. 2017;7(19):224–226.
  • Jeong HS, Lee TH, Bang CH, Kim JH, Hong SJ. Risk factors and outcomes of sepsis-induced myocardial dysfunction and stress-induced cardiomyopathy in sepsis or septic shock: a comparative retrospective study. Medicine. 2018;97(13):e0263. doi:10.1097/MD.0000000000010263
  • Khalid N, Patel PD, Alghareeb R, Hussain A, Maheshwari MV. The effect of sepsis on myocardial function: a review of pathophysiology, diagnostic criteria, and treatment. Cureus. 2022;14(6):e26178. doi:10.7759/cureus.26178
  • Yuan J, Chen M, Chen S, Hu C, Cai G, Yan J. 左心室整体纵向应变对脓毒症脓毒性休克患者预后影响的Meta分析 [Effect of left ventricular global longitudinal strain on prognosis of septic/septic shock patients: a meta analysis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018;30(9):842–847. Chinese.
  • Wang X, Su L, Yang R, et al. Myocardial strain/stress changes identified by echocardiography may reveal early sepsis-induced myocardial dysfunction. J Int Med Res. 2018;2018:30006051773743.
  • Ginsburg S, Conlon T, Himebauch A, et al. Left ventricular diastolic dysfunction in pediatric sepsis: outcomes in a single-center retrospective cohort study. Pediatr Crit Care Med. 2021;22:275–285. doi:10.1097/PCC.0000000000002668
  • de Braga Lima Carvalho Canesso M, Borges IN, de Deus Queiroz Santos TA, et al. Value of speckle-tracking echocardiography changes in monitoring myocardial dysfunction during treatment of sepsis: potential prognostic implications. Int J Cardiovasc Imaging. 2019;35(5):855–859.
  • Huang Y, Huo B, Luo W. Study on cardiac function and prognosis of sepsis patients with sepsis myocardial depression. China Med Pharmacy. 2017. Available from: https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFDLAST2017&filename=GYKX201719068&uniplatform=NZKPT&v=N3qdK13bSfKL5tEUYNUVBr4a2wGRFLsLc_BuTAJsXi01xUjHThzYpM45w-Sw4ke0
  • Velagapudi VM, Pidikiti R, Tighe DA. Is left ventricular global longitudinal strain by two-dimensional speckle tracking echocardiography in sepsis cardiomyopathy ready for prime time Use in the ICU? Healthcare. 2019;7:5.
  • Innocenti F, Palmieri V, Guzzo A, et al. SOFA score and left ventricular systolic function as predictors of short-term outcome in patients with sepsis. Intern Emerg Med. 2018;13:51–58. doi:10.1007/s11739-016-1579-3
  • Kaseer HS, Patel R, Tucker C, et al. Comparison of fluid resuscitation weight-based dosing strategies in obese patients with severe sepsis. Am J Emerg Med. 2021;49(19):268–272. doi:10.1016/j.ajem.2021.06.036
  • Loza-Gomez A, Hofmann E, Noklam C, et al. Severe sepsis and septic shock in patients transported by prehospital services versus walk in patients to the emergency department. Am J Emerg Med. 2020;45:173–178. doi:10.1016/j.ajem.2020.08.021
  • Hobai IA, Edgecomb J, Labarge K, et al. Dysregulation of intracellular calcium transporters in animal models of sepsis-induced cardiomyopathy. Shock. 2015;43(1):3. doi:10.1097/SHK.0000000000000261
  • Headley JM, Ahrens T. Narrative history of the swan-ganz catheter: development, education, controversies, and clinician acumen. AACN Adv Crit Care. 2020;31(1):25–33. doi:10.4037/aacnacc2020992
  • Garg J, Tyagi MS, Allana S. Assessing transvalvular aortic gradient with Swan-Ganz catheter. JACC Cardiovasc Interv. 2021;14:e123–e124. doi:10.1016/j.jcin.2021.03.014
  • Qi LP, Liu HW, Hong CM, et al. Effect of early invasive pulse indicator continuous cardiac output monitoring on prognosis of elderly patients with coronary heart disease and severe heart failure. Chin J Health Care Med. 2020;108(1):24–27.
  • Xia YM, Shi HP, Wu WD, et al. Efficacy of continuous renal replacement therapy in patients with sepsis complicated with acute kidney injury. Chin J Nosocomiol. 2019;98(17):e15257.
  • Tong HJ, Hu CB, Hao XJ, et al. Research progress of noninvasive cardiac output monitoring in the evaluation of fluid responsiveness in critically ill patients. Chin J Crit Care Med. 2015;27(1):76–78.
  • Zheng J, Ye M, Yu K, et al. Evaluation of volume reactivity in patients after cardiac surgery by non-invasive ultrasound cardiac output monitoring combined with passive leg lift test. Chin J Emerg Med. 2012;32(5):416–420.
  • Liu Z, Zhang Y. Progress in the application principle and clinical significance of pulse indicator continuous cardiac output monitoring technology. J Clin Oncol. 2015;12(1):1–8.
  • Horster S, Stemmler HJ, Strecker N, et al. Cardiac output measurements in septic patients: comparing the accuracy of USCOM to PiCCO. Crit Care Res Pract. 2012;2012:1–5. doi:10.1155/2012/270631
  • Kim JS, Kim M, Kim YJ, et al. Troponin testing for assessing sepsis-induced myocardial dysfunction in patients with septic shock. J Clin Med. 2019;8(2):239.
  • Innocenti F, Palmieri V, Stefanone VT, et al. Comparison of Troponin I levels versus myocardial dysfunction on prognosis in sepsis. Intern Emerg Med. 2021;17:223–231.
  • Vassalli F, Masson S, Meessen J, et al. Pentraxin-3, Troponin T, N-terminal pro-B-type natriuretic peptide in septic patients. Shock. 2020;54:675–680. doi:10.1097/SHK.0000000000001543
  • Vallabhajosyula S, Wang Z, Murad MH, et al.Natriuretic peptides to predict short-term mortality in patients with sepsis: a systematic review and meta-analysis. mayo clinic proceedings: innovations. Qual Outcomes. 2020;4(1):50–64.
  • Xiao Z, Liu J, Lu X, Xu Z, Luo H, Zhu Y. The clinical diagnostic value of plasma N-terminal b-type brain natriuretic peptide level in children with sepsis complicated with myocardial injury. Chin J Pediatr Emerg Med. 2014;2014(21):782–785.
  • Zang XF, Chen W, Sheng B, et al. The value of early cardiac ultrasound combined with cardiac biomarkers in predicting severe sepsis: a 5-year single-center retrospective study. Chin J Crit Care Med. 2018;30(4):332–336.
  • Li Z, Chen B, Li G. Progress in diagnosis and treatment of myocardial inhibition in sepsis. Chin J Circulation. 2015;2015(7):705–707.
  • Shortt C, Phan K, Hill SA, et al. Fatty acid binding protein and cardiac troponin I for the early rule-out of myocardial infarction in patients presenting with chest pain - ScienceDirect. Clin Biochem. 2012;45(13–14):1119. doi:10.1016/j.clinbiochem.2012.07.065
  • Chen Y-X, Li C-S. The prognostic and risk-stratified value of heart-type fatty-acid-binding protein in septic patients in emergency department. J Crit Care. 2014;29(4):512–516. doi:10.1016/j.jcrc.2014.03.026
  • Erenler AK, Yardan T, Duran L, et al. Usefulness of heart-type fatty acid binding protein in the emergency department. JPMA. 2013;63(9):1176–1181.
  • Fan ZM, Li Y, Tang M, et al. Progress in the application of antimicrobial peptides in the treatment of sepsis. Chin J Crit Care Med. 2021;33(5):626–629.
  • Fenglin G. Research progress of fluid resuscitation in patients with surgical sepsis. Chin J Minimal Invasive Surg. 2017;17(8):736–739.
  • Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486–552. doi:10.1097/CCM.0000000000002255
  • Boyd JH, Forbes J, Nakada TA, et al. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39(2):259. doi:10.1097/CCM.0b013e3181feeb15
  • Nunnally ME, Patel A. Sepsis - what’s new in 2019? Curr Opin Anesthesiol. 2019;32:163–168.
  • Stratton L, Berlin DA, Arbo JE. Vasopressors and inotropes in sepsis. Emerg Med Clin North Am. 2017;35:75–91.
  • Gelinas JP, Russell JA. Vasopressors during sepsis: selection and targets. Clin Chest Med. 2016;37(2):251–262. doi:10.1016/j.ccm.2016.01.008
  • Meddeb B, Hajjej Z, Romdhani C, et al. Effects of levosimendan on cellular metabolic alterations in patients with septic shock: a randomized controlled pilot study. Intensive Care Med Exp. 2017;48(3):307–312.
  • Yang F, Zhao LN, Sun Y, Chen Z. Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application. J Int Med Res. 2019;47:1817–1828.
  • Antcliffe DB, Santhakumaran S, Orme RML. Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trial. Intensive Care Med. 2019;45(10):1392–1400. doi:10.1007/s00134-019-05731-w
  • Chen J, Lai J, Yang L, et al. Trimetazidine prevents macrophage-mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin 1. Br J Pharmacol. 2015;173:545–561.
  • Tanoglu A, Yamanel L, Inal V, et al. Appreciation of trimetazidine treatment in experimental sepsis rat model. Bratisl Lek Listy. 2015;116(2):124–127. doi:10.4149/bll_2015_024
  • Shen WW, Xu QC, Qian Y, et al. Effects of β1 blockers on myocardial injury and prognosis in patients with early septic shock. J Clin Pharmacol. 2014;23(4):109–114.
  • L’Heureux M, Sternberg M, Brath L, et al. Sepsis-induced cardiomyopathy: a comprehensive review. Curr Cardiol Rep. 2020;22(5). doi:10.1007/s11886-020-01277-2
  • Mohan GK, Anil S, Hiren GD, et al. Continuous renal replacement therapy in children with severe sepsis and multiorgan dysfunction - a pilot study on timing of initiation. Indian J Crit Care Med. 2015;19(10):613.
  • Ye XL, Tao PI, Zhang R, et al. Effect of ulinastatin combined with continuous renal replacement therapy on intestinal mucosal barrier function in elderly patients with sepsis. Int J Med Health. 2017;23(1):4–12.
  • Wada K, Bunya N, Kakizaki R, et al. Successful use of veno‐arterial extracorporeal membrane oxygenation for septic cardiomyopathy in a patient with pre‐existing chronic heart failure. Acute Med Surg. 2019;6(3):301–304.
  • Bréchot N, Luyt CE, Schmidt M, et al. Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock. Crit Care Med. 2013;41(7):1616–1626. doi:10.1097/CCM.0b013e31828a2370
  • Li Y, Zhou G, Mo J. Clinical application of intra-aortic balloon counterpulsation in septic shock. J Shenyang Med Coll. 2016;18(4):265–266.
  • Takahashi Y, Sonoo T, Naraba H, et al. Effect of intra-arterial balloon pumping for refractory septic cardiomyopathy: a case series. Indian J Crit Care Med. 2019;23(4):182–185. doi:10.5005/jp-journals-10071-23150
  • Wang J, Jianguo LI, Huang F, et al. Application progress of PiCCO in diagnosis and treatment of ARDS patients. Med Recapitulate. 2019. Available from: https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFDLAST2019&filename=YXZS201914028&uniplatform=NZKPT&v=19lQY4BzrUoXyPrDaqqIXzlVBJRS5StQd7WILk6TcM2u4EXkg8Sm0lPpjqxlROYY